Primecap Management Portfolio holdings
AUM
$126B
This Quarter Return
+10.92%
1 Year Return
+17.42%
3 Year Return
+102.42%
5 Year Return
+196.08%
10 Year Return
+554.06%
AUM
$126B
AUM Growth
+$126B
(+6.6%)
Cap. Flow
-$3.18B
Cap. Flow
% of AUM
-2.52%
Top 10 Holdings %
Top 10 Hldgs %
35.91%
Holding
339
New
8
Increased
67
Reduced
188
Closed
5
Top Buys
| 1 |
Albemarle
ALB
|
$180M |
| 2 |
Bristol-Myers Squibb
BMY
|
$154M |
| 3 |
New Fortress Energy
NFE
|
$110M |
| 4 |
Boeing
BA
|
$78M |
| 5 |
Alibaba
BABA
|
$68.3M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$1.33B |
| 2 |
Eli Lilly
LLY
|
$503M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$432M |
| 4 |
Novartis
NVS
|
$171M |
| 5 |
JPMorgan Chase
JPM
|
$140M |
Sector Composition
| 1 | Technology | 31.73% |
| 2 | Healthcare | 30.82% |
| 3 | Industrials | 11.15% |
| 4 | Consumer Discretionary | 9.18% |
| 5 | Financials | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Globus Medical
GMED
$8.27B
| $2.78M | ﹤0.01% |
52,125
-300
| -0.6% | -$16K |
|
302
Marqeta
MQ
$2.86B
| $2.62M | ﹤0.01% |
375,200
+75,000
| +25% | +$524K |
|
303
Freshworks
FRSH
$3.93B
| $2.55M | ﹤0.01% |
108,500
-15,400
| -12% | -$362K |
|
304
Ingevity
NGVT
$2.13B
| $2.46M | ﹤0.01% |
52,000
| – | – |
|
305
Cboe Global Markets
CBOE
$24.7B
| $2.32M | ﹤0.01% |
13,000
-2,100
| -14% | -$375K |
|
306
Amylyx Pharmaceuticals
AMLX
$836M
| $2.31M | ﹤0.01% |
156,900
-148,000
| -49% | -$2.18M |
|
307
Snap
SNAP
$12.1B
| $2.26M | ﹤0.01% |
133,250
| – | – |
|
308
Veralto
VLTO
$26.4B
| $2.23M | ﹤0.01% |
+27,111
| New | +$2.23M |
|
309
Five Below
FIVE
$8B
| $1.94M | ﹤0.01% |
9,100
-100
| -1% | -$21.3K |
|
310
Tapestry
TPR
$21.2B
| $1.93M | ﹤0.01% |
+52,500
| New | +$1.93M |
|
311
Ambarella
AMBA
$3.5B
| $1.92M | ﹤0.01% |
31,300
-1,800
| -5% | -$110K |
|
|
LICY
312
DELISTED
Li-Cycle Holdings Corp.
LICY
| $1.92M | ﹤0.01% |
3,280,200
+90,800
| +3% | +$53.1K |
|
313
10x Genomics
TXG
$1.74B
| $1.76M | ﹤0.01% |
31,400
+1,300
| +4% | +$72.7K |
|
314
Arista Networks
ANET
$172B
| $1.68M | ﹤0.01% |
7,150
| – | – |
|
315
Jamf
JAMF
$1.24B
| $1.64M | ﹤0.01% |
90,900
| – | – |
|
|
SAGE
316
DELISTED
Sage Therapeutics
SAGE
| $1.62M | ﹤0.01% |
74,950
-14,900
| -17% | -$323K |
|
317
Greif Class B
GEF.B
$2.65B
| $1.58M | ﹤0.01% |
24,000
| – | – |
|
318
Sun Country Airlines
SNCY
$706M
| $1.56M | ﹤0.01% |
99,005
-900
| -0.9% | -$14.2K |
|
319
Mural Oncology
MURA
$35.7M
| $1.52M | ﹤0.01% |
+256,255
| New | +$1.52M |
|
320
NN Inc
NNBR
$129M
| $1.51M | ﹤0.01% |
377,400
-4,000
| -1% | -$16K |
|
321
Darden Restaurants
DRI
$24.1B
| $1.31M | ﹤0.01% |
8,000
| – | – |
|
|
SAFE
322
Safehold
SAFE
$1.18B
| $1.25M | ﹤0.01% |
53,600
| – | – |
|
323
Bloom Energy
BE
$12.4B
| $734K | ﹤0.01% |
49,600
| – | – |
|
324
ZimVie
ZIMV
$532M
| $719K | ﹤0.01% |
40,510
-149,500
| -79% | -$2.65M |
|
325
Adaptive Biotechnologies
ADPT
$2.01B
| $716K | ﹤0.01% |
146,190
| – | – |
|